Drug
Letrozole
Letrozole: highest development phase Phase 2, developed by Dr. Reddy's, Gedeon Richter, Novartis. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Dr. Reddy's, Gedeon Richter, Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Letrozole 5 mg NCT04524026 | Phase 2 | IVF |
| Letrozole NCT00247663 | Phase 2 | Postmenopausal Women With Advanced Breast Cancer |
| Letrozole NCT01375452 | Phase 1 | Healthy |
Latest
No recent events.
Follow Letrozole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.